Immediate Impact

59 standout
Sub-graph 1 of 23

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape
2024 Standout
3 intermediate papers

Works of Talal Amer being referenced

A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma
2009

Author Peers

Author Last Decade Papers Cites
Talal Amer 207 53 117 82 25 370
Salvatore Garofalo 113 34 77 63 31 306
Elodie Miquelestorena‐Standley 63 90 38 68 28 406
Qingle Zeng 147 51 101 125 34 377
Carlos Marín 169 58 64 65 32 333
Neda Zarrin‐Khameh 108 114 32 18 40 341
Mahesh Kumar Mittal 170 109 44 32 33 351
M Ida 136 69 179 131 18 388
Toshihito Shinagawa 110 96 30 89 46 409
Nick Shillingford 129 39 96 181 34 340
A Leinonen 214 138 27 38 26 343

All Works

Loading papers...

Rankless by CCL
2026